FDMT Earnings

Quarterly EPS
$-0.79
Q3 2024
$-0.89
Q4 2024
$-0.86
Q1 2025
$-0.98
Q2 2025
$-1.01
Q3 2025
$0.30
Q4 2025
$-1.01
Q1 2026
$-1.04
Q2 2026
Latest Revenue3.8M
Latest Net Income-72936000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.043.8M-72936000+25,106.7%-6.1%
Q1 2026-$1.013.0M-68760000+21,664.3%-17.4%
Q4 2025$0.3085.1M19.4M+8,508,900.0%+133.7%
Q3 2025-$1.0190.0K-56876000+2,900.0%-27.8%
Q2 2025-$0.9815.0K-54658000+200.0%-55.6%
Q1 2025-$0.8614.0K-47972000-50.0%-30.3%
Q4 2024-$0.891.0K-49671000——
Q3 2024-$0.793.0K-43843000-100.0%-229.2%
Q2 2024-$0.635.0K-34953000——
Q1 2024-$0.6628.0K-32401000——
Q4 2023—————
Q3 2023-$0.2420.2M-10256000——
4D Molecular Therapeutics (FDMT) — Earnings